Hormonal contraceptives and endometriosis/adenomyosis
editorial
OA: closed
CC0
⤵ 12 in-corpus citations
AI-generated summary
Hormonal contraceptives, particularly combined estrogen/progestogen and continuous progestogen-only therapies, are cost-effective treatments for various forms of endometriosis and adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Over the past 50 years hormonal contraceptives have gradually developed to be cost-effective medical treatment modalities for primary and secondary therapy of endometriosis/adenomyosis. This is particularly true for the various estrogen/progestogen combinations as monophasic - particularly progestogen-dominant - preparations in cyclic, long-cyclic and continuous treatment forms. An alternative is the progestogen-only therapy used continuously. Therapeutic effects have been shown for peritoneal, ovarian and deep-infiltrating endometriosis as well as for adenomyosis. An individualized, medical long-term treatment concept to control endometriosis/adenomyosis-related symptoms, endometriosis/adenomyosis development and minimizing the recurrence rate needs to be further studied in women, who do not desire to become pregnant.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (23)
- Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
- Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium via openalex
- [Hormone therapy of endometriosis--principles and clinical aspects of gestagen treatment]. via openalex
- Is There a Role for Use of Levonorgestrel Intrauterine System in Women with Chronic Pelvic Pain? via openalex
- Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex
- Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex
- Medical treatment of endometriosis: a comparative trial. via openalex
- Non-contraceptive benefits of hormonal contraceptives. via openalex
- Non-contraceptive health benefits of oral contraceptives via openalex
- Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)—A systematic enquiry and overview via openalex
- Norethisterone acetate in the treatment of colorectal endometriosis: a pilot study via openalex
- Pathophysiology, diagnosis and treatment of endometriosis. via openalex
- Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex
- Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision via openalex
- Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis via openalex
- Recurrence rate of endometrioma after laparoscopic cystectomy: A comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo via openalex
- Reprint of Classification and pharmacology of progestins via openalex
- The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease via openalex
- The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis via openalex
- The pathophysiology of endometriosis and adenomyosis: tissue injury and repair via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W2171452401 via openalex
- W2045089102 via openalex
Cited by (12)
- Safety and Efficacy of Radiofrequency Ablation for Abdominal Wall Endometriosis: A Single-center Experience 2026
- Is high-intensity focused ultrasound a magical solution to endometriosis? A systematic review 2024
- Comparison of Patients with Adenomyosis Detected in Hysterectomy Material and Patients with Other Benign Pathologies: Retrospective Study 2024
- El tratamiento hormonal es imperativo para todas las pacientes: lo antes posible y siempre 2023
- Safety and efficacy of microwave ablation for abdominal wall endometriosis: A retrospective study 2023
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review 2021
- Abdominal wall endometriosis treatment by ultrasound-guided high-intensity focused ultrasound ablation: a case report 2018
- Ultrasound‐guided high‐intensity focused ultrasound treatment for abdominal wall endometriosis: a retrospective study 2017
- Current and Future Medical Treatment of Adenomyosis 2016
- <i>β</i> ‐Catenin activation contributes to the pathogenesis of adenomyosis through epithelial–mesenchymal transition 2013
- Adenomyosis: A Challenge in Clinical Gynecology 2012
- Application of Mini-abdominoplasty after Conservative Excision of Extensive Cesarean Scar Endometriosis 2012
Source provenance
- europepmc
- last seen: 2026-06-19T06:14:56.452680+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:16:54.825375+00:00
License: CC0
· commercial use OK